+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Vaccine Vials Market Research Report by Type, by Material, by Capacity, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5146104
  • Report
  • July 2021
  • Region: Global
  • 184 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Vaccine Vials Market will Grow to USD 856.59 Million by 2026, at a CAGR of 10.65%

FEATURED COMPANIES

  • Berlin Packaging LLC
  • Catalent, Inc.
  • DWK Life Sciences GmbH
  • JOTOP Glass
  • Qorpak, Inc.
  • SiO2 Medical Products
The Global Vaccine Vials Market size was estimated at USD 466.58 Million in 2020 and expected to reach USD 514.72 Million in 2021, at a Compound Annual Growth Rate (CAGR) 10.65% to reach USD 856.59 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Vaccine Vials to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the Vaccine Vials Market was studied across Multi Dose and Single Dose.
  • Based on Application, the Vaccine Vials Market was studied across Preventive Vaccine and Therapeutic Vaccine.
  • Based on Material, the Vaccine Vials Market was studied across Glass and Polymer.
  • Based on Capacity, the Vaccine Vials Market was studied across 10ml, 20ml, 2ml, 3ml, and 5ml.
  • Based on Region, the Vaccine Vials Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vaccine Vials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Vaccine Vials Market, including Anhui Huaxin Medicinal Glass Products Co., Ltd., Berlin Packaging LLC, Cardinal Health, Inc., Catalent, Inc., Corning Inc., DWK Life Sciences GmbH, Gerresheimer AG, Jinan Youlyy Industrial Co., Ltd., JOTOP Glass, Nipro Corporation, Origin Pharmaceuticals Ltd, Pacific Vial Manufacturing Inc., Qorpak, Inc., Richland Glass Company, Inc., SCHOTT AG, Shandong Pharmaceutical Glass Co., Ltd., SiO2 Medical Products, Stevanato Group, Thermo Fisher Scientific Inc, and Vetter Pharma-Fertigung GmbH & Co. KG..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Vaccine Vials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vaccine Vials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vaccine Vials Market?
4. What is the competitive strategic window for opportunities in the Global Vaccine Vials Market?
5. What are the technology trends and regulatory frameworks in the Global Vaccine Vials Market?
6. What is the market share of the leading vendors in the Global Vaccine Vials Market?
7. What modes and strategic moves are considered suitable for entering the Global Vaccine Vials Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Berlin Packaging LLC
  • Catalent, Inc.
  • DWK Life Sciences GmbH
  • JOTOP Glass
  • Qorpak, Inc.
  • SiO2 Medical Products
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Application Outlook
3.5. Material Outlook
3.6. Capacity Outlook
3.7. Region Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for a large number of vaccines for the sales of vaccine vials
5.1.1.2. High prevalence of infectious diseases and rise of pharmaceutical industries
5.1.1.3. Growing initiatives from government and private organizations to advance vaccination
5.1.2. Restraints
5.1.2.1. Lack of healthcare infrastructure in developing countries such as Brazil, India, and China
5.1.3. Opportunities
5.1.3.1. Rising awareness of immunization among the people regarding the endemic diseases
5.1.3.2. Development of innovative vaccine administration methods
5.1.3.3. Attractive investment in Vaccine vial monitor (VVM)
5.1.4. Challenges
5.1.4.1. High-cost associated with the supply chain of vaccine vials
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Vaccine Vials Market, by Type
6.1. Introduction
6.2. Multi Dose
6.3. Single Dose

7. Vaccine Vials Market, by Application
7.1. Introduction
7.2. Preventive Vaccine
7.3. Therapeutic Vaccine

8. Vaccine Vials Market, by Material
8.1. Introduction
8.2. Glass
8.3. Polymer

9. Vaccine Vials Market, by Capacity
9.1. Introduction
9.2. 10ml
9.3. 20ml
9.4. 2ml
9.5. 3ml
9.6. 5ml

10. Americas Vaccine Vials Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Vaccine Vials Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Thailand

12. Europe, Middle East & Africa Vaccine Vials Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Anhui Huaxin Medicinal Glass Products Co., Ltd.
14.2. Berlin Packaging LLC
14.3. Cardinal Health, Inc.
14.4. Catalent, Inc.
14.5. Corning Inc.
14.6. DWK Life Sciences GmbH
14.7. Gerresheimer AG
14.8. Jinan Youlyy Industrial Co., Ltd.
14.9. JOTOP Glass
14.10. Nipro Corporation
14.11. Origin Pharmaceuticals Ltd
14.12. Pacific Vial Manufacturing Inc.
14.13. Qorpak, Inc.
14.14. Richland Glass Company, Inc.
14.15. SCHOTT AG
14.16. Shandong Pharmaceutical Glass Co., Ltd.
14.17. SiO2 Medical Products
14.18. Stevanato Group
14.19. Thermo Fisher Scientific Inc
14.20. Vetter Pharma-Fertigung GmbH & Co. KG.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL VACCINE VIALS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 3. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2020 (USD MILLION)
FIGURE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2020 (USD MILLION)
FIGURE 6. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 7. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL VACCINE VIALS MARKET: MARKET DYNAMICS
FIGURE 9. GLOBAL VACCINE VIALS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2026
FIGURE 13. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 18. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2026
FIGURE 20. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 24. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2020 VS 2026 (%)
FIGURE 25. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2020 VS 2026 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2026
FIGURE 27. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, 2018-2026 (USD MILLION)
FIGURE 30. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 31. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2020 VS 2026 (%)
FIGURE 32. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2020 VS 2026 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2026
FIGURE 34. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 38. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 42. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, 2018-2026 (USD MILLION)
FIGURE 43. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 44. AMERICAS VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. ARGENTINA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. BRAZIL VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. CANADA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. MEXICO VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. UNITED STATES VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. AUSTRALIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. CHINA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. INDIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. INDONESIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. JAPAN VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. MALAYSIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. PHILIPPINES VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. SINGAPORE VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. SOUTH KOREA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. THAILAND VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. FRANCE VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. GERMANY VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. ITALY VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. NETHERLANDS VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. QATAR VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. RUSSIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. SAUDI ARABIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. SOUTH AFRICA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. SPAIN VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. UNITED KINGDOM VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. GLOBAL VACCINE VIALS MARKET: FPNV POSITIONING MATRIX
FIGURE 74. GLOBAL VACCINE VIALS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 75. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VACCINE VIALS MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL VACCINE VIALS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. AMERICAS VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. ARGENTINA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. BRAZIL VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. CANADA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. MEXICO VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. AUSTRALIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. CHINA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. INDIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. INDONESIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. JAPAN VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. MALAYSIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. PHILIPPINES VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. SINGAPORE VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. SOUTH KOREA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. THAILAND VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. FRANCE VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. GERMANY VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. ITALY VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. NETHERLANDS VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. QATAR VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. RUSSIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. SAUDI ARABIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. SOUTH AFRICA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. SPAIN VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. UNITED KINGDOM VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. GLOBAL VACCINE VIALS MARKET: SCORES
TABLE 49. GLOBAL VACCINE VIALS MARKET: BUSINESS STRATEGY
TABLE 50. GLOBAL VACCINE VIALS MARKET: PRODUCT SATISFACTION
TABLE 51. GLOBAL VACCINE VIALS MARKET: RANKING
TABLE 52. GLOBAL VACCINE VIALS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 53. GLOBAL VACCINE VIALS MARKET: MERGER & ACQUISITION
TABLE 54. GLOBAL VACCINE VIALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 55. GLOBAL VACCINE VIALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 56. GLOBAL VACCINE VIALS MARKET: INVESTMENT & FUNDING
TABLE 57. GLOBAL VACCINE VIALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 58. GLOBAL VACCINE VIALS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Anhui Huaxin Medicinal Glass Products Co., Ltd.
  • Berlin Packaging LLC
  • Cardinal Health, Inc.
  • Catalent, Inc.
  • Corning Inc.
  • DWK Life Sciences GmbH
  • Gerresheimer AG
  • Jinan Youlyy Industrial Co., Ltd.
  • JOTOP Glass
  • Nipro Corporation
  • Origin Pharmaceuticals Ltd
  • Pacific Vial Manufacturing Inc.
  • Qorpak, Inc.
  • Richland Glass Company, Inc.
  • SCHOTT AG
  • Shandong Pharmaceutical Glass Co., Ltd.
  • SiO2 Medical Products
  • Stevanato Group
  • Thermo Fisher Scientific Inc
  • Vetter Pharma-Fertigung GmbH & Co. KG.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll